Objectif "One of the most perplexing phenomena of the human mind is the conviction of perceiving a ""voice"" in the absence of an external auditory source. This is called an auditory hallucination (AH), and is the most characteristic symptom of the most severe mental disorder, schizophrenia. Understanding the phenomenology, cognitive, and neurobiological underpinnings of AHs will not only provide new insights for explaining schizophrenia, but will also provide new insights into the ""complexities of the mind"". In my previous research, I have uncovered the neurocognitive markers of the initiation of an AH, focusing on what causes the onset of a hallucinatory episode. The current proposal further narrows the focus, asking a single question; why do AHs spontaneously come-and-go over time, or stated otherwise, why are they not permanently present once initiated? If we believe that the onset of an episode has neurocognitive markers, which all evidence supports, then we must also acknowledge that the offset must have corresponding markers. This question has to my knowledge never been addressed, although it is vital for the understanding of the underlying mechanisms, and for new treatment strategies. I will track the fluctuations of AH episodes in real-time with iPhone app technology, going beyond interview questionnaires. I will track how cognition modulates the onset and offset with an experimental dichotic listening paradigm, going beyond standard tests. I will track what happens in the brain the few seconds before the onset and, in particular the offset of an episode, using component-based fMRI analysis, going beyond ""blobology"". I will track with MR spectroscopy the interaction of excitatory and inhibitory transmitters that are hypothesized to mediate episode onsets and offsets, respectively, going beyond systems imaging. Thus, I will track AH episodes from the clinical to the receptor level, working vertically through a “levels of explanation” model, from higher to lower levels" Champ scientifique medical and health sciencesclinical medicinepsychiatryschizophreniamedical and health sciencesclinical medicineclinical neurologynatural sciencesphysical sciencesopticsspectroscopy Programme(s) H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC) Main Programme Thème(s) ERC-ADG-2015 - ERC Advanced Grant Appel à propositions ERC-2015-AdG Voir d’autres projets de cet appel Régime de financement ERC-ADG - Advanced Grant Institution d’accueil UNIVERSITETET I BERGEN Contribution nette de l'UE € 2 413 371,00 Adresse MUSEPLASSEN 1 5020 Bergen Norvège Voir sur la carte Région Norge Vestlandet Vestland Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 2 413 371,00 Bénéficiaires (1) Trier par ordre alphabétique Trier par contribution nette de l'UE Tout développer Tout réduire UNIVERSITETET I BERGEN Norvège Contribution nette de l'UE € 2 413 371,00 Adresse MUSEPLASSEN 1 5020 Bergen Voir sur la carte Région Norge Vestlandet Vestland Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 2 413 371,00
